Tag: Globulin
HepaGam B [Hepatitis B Immune Globulin (Human) Injection] – Theoretical Risk of Thrombotic Events with Intravenous Administration and Related Labeling Update
The manufacturer of HepaGam B [Hepatitis B Immune Globulin (Human) Injection], a drug used for the prevention of hepatitis B recurrence in liver transplant patients, will update the product monograph to include the theoretical risk of blood clots. Health Canada RSS – MedEffect Canada – Advisories and Recalls for Health Professionals
HepaGam B [Hepatitis B Immune Globulin (Human) Injection] – Theoretical Risk of Thrombotic Events with Intravenous Administration and Related Labeling Update
The manufacturer of HepaGam B [Hepatitis B Immune Globulin (Human) Injection], a drug used for the prevention of hepatitis B recurrence in liver transplant patients, will update the product monograph to include the theoretical risk of blood clots. Health Canada RSS – MedEffect Canada – Advisories and Recalls for the Public
Privigen, Immune Globulin Intravenous (Human) – Association of Hemolysis Following Administration and Related Labeling Update
Cases of hemolysis, some complicated by renal failure and disseminated intravascular coagulation, have been reported following the administration of Privigen. Risk factors for hemolysis include the use of high doses, a non-O blood group and possibly an underlying inflammatory state. Health Canada RSS – MedEffect Canada – Advisories and Recalls for the Public
Privigen, Immune Globulin Intravenous (Human) – Association of Hemolysis Following Administration and Related Labeling Update
Cases of hemolysis, some complicated by renal failure and disseminated intravascular coagulation, have been reported following the administration of Privigen. Risk factors for hemolysis include the use of high doses, a non-O blood group and possibly an underlying inflammatory state. Health Canada RSS – MedEffect Canada – Advisories and Recalls for Health Professionals
